Progressive resistance training for adults with external snapping hip
Official title: Snappy Hip Trial: A Randomized Crossover Trial Comparing the Clinical and Cost-effectiveness of Progressive Resistance Training Compared to Usual Care on Pain for Adults With External Snapping Hip
Run by University of Aarhus · NCT06924164 · Data updated 2026-11-12
This project will test whether a 12-week progressive resistance training program can reduce hip pain and improve function in adults 18–40 with external snapping hip compared with waiting or self-guided exercise.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Aarhus Academic / other |
| Locations | 13 sites (Aalborg and 12 other locations) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | April 1, 2027 |
| Study ends | April 1, 2027 |
| Registry record updated | October 7, 2026 |
| Trial ID | NCT06924164 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–40 who can reproduce an audible or visible lateral hip 'snap' with recent pain, can commute to the training facility, and understand Danish or English are the ideal candidates.
✕Probably not a fit
Patients with previous hip surgery, predominant anterior or medial hip pain, contraindications to exercise, pregnancy, planned lower-extremity surgery, or other neurological/rheumatoid conditions affecting the hip are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This international, multicentre, randomized, assessor-blinded crossover trial will compare a 12-week progressive resistance training program to a wait-and-see control with self-guided exercise in adults with external snapping hip. After baseline testing, participants aged 18–40 will be randomized 1:1 using REDCap and undergo follow-up testing at 6, 12, and 24 weeks, with the primary outcome measured as change from baseline to 12 weeks. The trial is powered for the 12-week endpoint and uses blinded assessors and multiple follow-up time points to capture both short- and longer-term effects. Recruitment and training take place at Danish centers in Aalborg, Aarhus, and Copenhagen and participants must be able to attend in-person sessions and read Danish or English.
Why it matters
Potential benefit: If successful, this program could provide a specific non-surgical option that reduces hip pain and improves function for people with external snapping hip.
How similar studies have gone: A prior feasibility study reported less pain and improved physical function, quality of life, and strength after 12 weeks of progressive resistance training, so this randomized trial builds on promising preliminary results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Age 18-40 years (10) * Experienced lateral hip joint "snapping" with pain discomfort within the last 14 days * Able to demonstrate the audible and/or visible lateral "snapping" during lateral hip joint movementor popping sound when the hip joint moves * Capable of commuting to the training facility * Proficient in reading and understanding Danish or English Exclusion criteria: * Previous surgery on the affected hip * Planned surgery on lower extremities within the trial period * Anterior or medial hip discomfort that substantially exceeds the lateral hip discomfort * Any contraindication to exercise * Neurological, rheumatoid, or mental conditions affecting the hip function * Ongoing active cancer treatment * Planned vacation for more than 14 days within the intervention period * Pregnancy
Where it's running
-
Aarhus University Hospital
Aarhus N, Denmark Recruiting -
Regionshospitalet Horsens
Horsens, Denmark Recruiting -
Aalborg Universitetshospital
Aalborg, Denmark Not yet recruiting -
Rigshospitalet
Copenhagen, Denmark Not yet recruiting -
Bispebjerg og Frederiksberg Hospital
Copenhagen, Denmark Not yet recruiting -
Regionshospitalet Gødstrup
Herning, Denmark Not yet recruiting
Show 7 more locations
-
Nordsjællands Hospital - Hillerød
Hillerød, Denmark Not yet recruiting -
Hvidovre Hospital
Hvidovre, Denmark Not yet recruiting -
Sjællands Universitetshospital - Køge
Køge, Denmark Not yet recruiting -
Næstved, Slagelse og Ringsted Hospital
Næstved, Denmark Not yet recruiting -
Odense Universitetshospital
Odense, Denmark Not yet recruiting -
Regionshospitalet Randers
Randers, Denmark Not yet recruiting -
Sygehus Lillebælt - Vejle
Vejle, Denmark Not yet recruiting
Study contacts
- Principal investigator: Lisa U Tønning, MHSc — Department of Orthopedic Surgery, Aarhus University Hospital, DK
- Study coordinator: Lisa U Tønning, MHSc
- Email: lisatoenning@clin.au.dk
- Phone: +4526474080
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bioimpedance Spectroscopy for Fluid Changes in Hemodialysis Patients
This study tests whether raw bioimpedance data can help doctors gauge fluid changes in people on hemodialysis and guides fluid removal decisions.
-
PRODIAP: See if patient-reported outcomes improve care for people with type 2 diabetes in general practice
A large Danish trial tests whether using a diabetes-specific patient-reported outcomes questionnaire in general practice helps tailor care for people with type 2 diabetes.
-
Conquer Fear Carer Brief: A Quick Online Therapy for Caregivers Facing Cancer Progression
A short online program helps caregivers of patients with metastatic cancer see if a brief psychological therapy can reduce their fear of cancer progression and be acceptable to them.
-
Tailored rehab for young adults with cancer
This pilot trial tests a youth-focused rehabilitation program called YATAC to see if it’s feasible and acceptable for adults 18-39 with cancer who are in municipal rehab settings.
-
Nitrous Oxide in Blood, Breath, and Urine After Different Exposures
This study tests how nitrous oxide appears in blood, breath, and urine after three different exposures in adults.
-
Disrupted congestion in acute heart failure: can ultrasound at discharge predict readmission and death
This study tests whether ultrasound checks of congestion at discharge can predict which patients with acute heart failure are more likely to be readmitted or die within 90 days.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.